ProShare Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,153
Closed -$14K 1906
2022
Q3
$14K Buy
12,153
+948
+8% +$1.09K ﹤0.01% 1729
2022
Q2
$20K Sell
11,205
-24,690
-69% -$44.1K ﹤0.01% 1768
2022
Q1
$73K Sell
35,895
-7,056
-16% -$14.4K ﹤0.01% 2080
2021
Q4
$117K Buy
42,951
+3,199
+8% +$8.71K ﹤0.01% 2176
2021
Q3
$177K Sell
39,752
-4,909
-11% -$21.9K ﹤0.01% 1816
2021
Q2
$259K Buy
44,661
+7,891
+21% +$45.8K ﹤0.01% 1981
2021
Q1
$258K Buy
36,770
+4,766
+15% +$33.4K ﹤0.01% 1889
2020
Q4
$154K Buy
32,004
+21,837
+215% +$105K ﹤0.01% 1917
2020
Q3
$59K Buy
+10,167
New +$59K ﹤0.01% 1580
2019
Q4
Sell
-20,532
Closed -$81K 1812
2019
Q3
$81K Sell
20,532
-1,272
-6% -$5.02K ﹤0.01% 1569
2019
Q2
$324K Sell
21,804
-3,476
-14% -$51.7K ﹤0.01% 1201
2019
Q1
$627K Buy
25,280
+845
+3% +$21K ﹤0.01% 943
2018
Q4
$439K Sell
24,435
-4,718
-16% -$84.8K ﹤0.01% 993
2018
Q3
$856K Sell
29,153
-454
-2% -$13.3K 0.01% 891
2018
Q2
$1.35M Sell
29,607
-647
-2% -$29.4K 0.01% 729
2018
Q1
$1.6M Sell
30,254
-3,996
-12% -$211K 0.01% 668
2017
Q4
$2.33M Buy
34,250
+2,539
+8% +$173K 0.02% 577
2017
Q3
$2.61M Buy
31,711
+4,914
+18% +$405K 0.02% 507
2017
Q2
$2.51M Sell
26,797
-1,248
-4% -$117K 0.03% 507
2017
Q1
$1.79M Sell
28,045
-2,552
-8% -$163K 0.02% 588
2016
Q4
$1.36M Buy
30,597
+2,658
+10% +$118K 0.02% 658
2016
Q3
$1.01M Sell
27,939
-5,645
-17% -$203K 0.01% 678
2016
Q2
$461K Buy
33,584
+1,056
+3% +$14.5K 0.01% 1011
2016
Q1
$625K Sell
32,528
-3,601
-10% -$69.2K 0.01% 901
2015
Q4
$1.27M Buy
36,129
+3,125
+9% +$109K 0.02% 655
2015
Q3
$3.04M Buy
33,004
+2,648
+9% +$244K 0.04% 367
2015
Q2
$2.67M Sell
30,356
-1,820
-6% -$160K 0.04% 419
2015
Q1
$2.39M Buy
32,176
+4,383
+16% +$325K 0.03% 510
2014
Q4
$1.56M Buy
27,793
+487
+2% +$27.3K 0.02% 648
2014
Q3
$1.24M Sell
27,306
-5,307
-16% -$241K 0.02% 997
2014
Q2
$1.35M Sell
32,613
-11,489
-26% -$476K 0.02% 1022
2014
Q1
$3.06M Buy
44,102
+27,906
+172% +$1.93M 0.04% 504
2013
Q4
$976K Sell
16,196
-4,488
-22% -$270K 0.01% 983
2013
Q3
$1.26M Buy
20,684
+6,782
+49% +$412K 0.03% 696
2013
Q2
$931K Buy
+13,902
New +$931K 0.02% 895